TY - JOUR
T1 - Ocular complications of cancer therapy
T2 - A primer for the ophthalmologist treating cancer patients
AU - Hazin, Ribhi
AU - Abuzetun, Jamil Y.
AU - Daoud, Yassine J.
AU - Abu-Khalaf, Maysa M.
PY - 2009/7/1
Y1 - 2009/7/1
N2 - PURPOSE OF REVIEW: Cancer patients may develop ocular complications secondary to direct or metastatic involvement with cancer, radiation exposure, or chemotherapy. As many as 1.4 million new cancer cases arise in the United States annually. RECENT FINDINGS: Chemotherapy administration remains a critical aspect of treating many cancers and offers improved prognosis and prolonged survival in many cases; however, these therapies are known to cause a wide range of toxicities. SUMMARY: Ocular side effects such as photophobia, cataracts, glaucoma, retinopathy, and other ocular toxicities have been reported following chemotherapy administration. To effectively treat cancer patients, oncologists, primary care clinicians, and ophthalmologists should be aware of the potential ophthalmic toxicities certain widely used chemotherapeutic agents and radiation therapy may pose to their patients, particularly in the setting of preexisting ocular conditions.
AB - PURPOSE OF REVIEW: Cancer patients may develop ocular complications secondary to direct or metastatic involvement with cancer, radiation exposure, or chemotherapy. As many as 1.4 million new cancer cases arise in the United States annually. RECENT FINDINGS: Chemotherapy administration remains a critical aspect of treating many cancers and offers improved prognosis and prolonged survival in many cases; however, these therapies are known to cause a wide range of toxicities. SUMMARY: Ocular side effects such as photophobia, cataracts, glaucoma, retinopathy, and other ocular toxicities have been reported following chemotherapy administration. To effectively treat cancer patients, oncologists, primary care clinicians, and ophthalmologists should be aware of the potential ophthalmic toxicities certain widely used chemotherapeutic agents and radiation therapy may pose to their patients, particularly in the setting of preexisting ocular conditions.
KW - Cancer
KW - Cataracts
KW - Chemotherapy
KW - Conjunctivitis
KW - Dry eye syndrome
KW - Glaucoma
KW - Ocular complications
KW - Radiation therapy
UR - http://www.scopus.com/inward/record.url?scp=67651009687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67651009687&partnerID=8YFLogxK
U2 - 10.1097/ICU.0b013e32832c9007
DO - 10.1097/ICU.0b013e32832c9007
M3 - Review article
C2 - 19491683
AN - SCOPUS:67651009687
SN - 1040-8738
VL - 20
SP - 308
EP - 317
JO - Current opinion in ophthalmology
JF - Current opinion in ophthalmology
IS - 4
ER -